SLStefano Likaj

Stefano Likaj

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stefano Likaj has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association Between Medication Adherence and Quality of Life in Adults Living with One Chronic Condition or Multimorbidity—A Cross-Sectional Study

    by Stefano Likaj, Enkeleint A. Mechili, Ercole Vellone, Brunilda Subashi, Erlini Kokalla

    Introduction: Medication adherence (MA) remains a major challenge in the long-term management of chronic conditions and may be associated with patients’ quality of life (QoL). Evidence regarding this relationship among adults in Albania remains limited. This study aimed to investigate the association between MA and QoL among adults receiving long-term pharmacological treatment in primary healthcare settings in Vlorë and Orikum, Albania. Methods: An observational, descriptive, cross-sectional multicenter study was conducted between June and December 2025 among 395 adults aged 18–64 years with at least one chronic condition requiring long-term pharmacological treatment. Participants were recruited consecutively from six primary healthcare centers. MA was assessed using the SMAQ tool, while QoL was evaluated using the WHOQOL-BREF. Associations were examined using chi-square/Fisher’s exact tests, Mann–Whitney U tests, binary logistic regression, and multiple linear regression. Statistical significance was set at p ≤ 0.05. Results: Overall, 22.5% of participants were classified as adherent and 77.5% as non-adherent. In multivariable analysis, higher educational attainment, being married/cohabiting, and taking up to two medications daily were independently associated with greater odds of adherence. Adherent participants had significantly higher scores for overall QoL, satisfaction with health, physical health, psychological health, and environmental health (all p ≤ 0.002), while no significant difference was observed for social relationships. In adjusted linear regression models, MA remained independently associated with overall QoL (B = 8.05, p = 0.026), psychological health (B = 9.07, p = 0.003), and environmental health (B = 5.43, p = 0.043), but not with physical health or social relationships. Higher educational attainment was consistently associated with better QoL across all domains, whereas multimorbidity was not independently associated with QoL outcomes. Discussion: Medication non-adherence was highly prevalent among adults with chronic conditions. MA was independently associated with selected dimensions of QoL, while educational attainment emerged as a consistent correlate of well-being. Conclusions: These findings highlight the relevance of adherence assessment and patient education in chronic disease management. Further longitudinal studies are needed to clarify the temporal relationships between medication adherence and QoL.

  • Open Access

    Impact of Medication Adherence and Quality of Life in Adults With a Single Chronic Condition or Multimorbidity: A Narrative Review

    by Stefano Likaj, Brunilda Subashi, Erlini Kokalla, Emirjona Kicaj, Enkeleint A. Mechili

    Introduction. Medication adherence plays a critical role in the clinical management of chronic conditions and may significantly influence patients' quality of life (QoL). Understanding this relationship is particularly important in populations with multimorbidity. Focusing on the problem of chronic conditions and multimorbidity in young adults is crucial because they represent the active part of society and chronicity is now public health concern due to the high number of incidence and mortality among this group population. Methods. An extensive literature search was conducted in the PubMed/MEDLINE, Scopus, and Web of Science databases for the period 2014–2024. The search strategy used both Medical Subject Headings (MeSH) and keywords related to medication adherence, quality of life, chronic conditions, and adult populations. Original, full-text articles published in English between 2014 and 2024 were included if they involved adults aged 18–65 with one or more chronic conditions (e.g., diabetes, hypertension, COPD), living in community settings. Eligible studies employed RCTs, cohort, cross-sectional, case-control, qualitative, or mixed-methods designs and reported on both medication adherence and quality of life. Studies were excluded if they focused on psychiatric, oncologic, surgical, transplant, or dialysis populations, hospital-based settings, or lacked relevant adherence and quality of life outcomes. This review is in PROSPERO with code CRD42025641905 Results. Eleven studies were included, cross-sectional, randomized control trial, mixed methods, semi directive interview. Most studies demonstrated a positive association between medication adherence and quality of life, with higher adherence linked to better physical, psychological, and social well-being. Pharmacist-led interventions and digital tools emerged as effective strategies for improving adherence. However, heterogeneity in measurement tools and study populations limited comparability. Discussion. Medication adherence is a key modifiable factor influencing quality of life among individuals with chronic conditions and multimorbidity. Multidimensional adherence-enhancing strategies—including education, patient empowerment, and system-level changes—are essential. Future research should adopt robust methodologies and standardized outcome measures to better inform clinical practice and policy.